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Chemicals and signaling molecules released by injured cells at the beginning of wound healing prompt inflammation. In diabetes,
prolonged inflammation is one of the probable causes for delayed wound healing. Increased levels of cyclooxygenase-2 (cox-2),
interleukin–6 (IL-6), and tumour necrosis factor-alpha (TNF-α) are associated with the inflammatory response and in diabetes,
and increased levels of these contribute to chronic wounds that do not heal. Rising levels of cox-2, IL-6, and TNF-α have also
been associated with increased oxidative stress. Photobiomodulation (PBM) may impact wound healing processes by affecting
the signaling pathways and molecules pertinent to tissue repair. In the present study, the effect of PBM (wavelength: 660 nm;
energy density: 5 J/cm2) on levels of cox-2, IL-6, and TNF-α was determined in fibroblast cell culture models. Four WS1 models
(normal, normal wounded, diabetic, and diabetic wounded) were irradiated at 660 nm, and the culture media was collected at 0,
24, and 48 h postirradiation. Cells that were not irradiated (0 J/cm2) served as the controls. The following parameters were
determined postirradiation: cell morphology using light microscopy, cell viability using the Trypan Blue exclusion assay, and
levels of the inflammatory markers cox-2, IL-6, and TNF-α were measured using ELISA. Cell migration increased in the
wounded groups over the 48 h interval after PBM; viability improved postirradiation in the diabetic wounded groups at 0 and
24 h (P ≤ 0:05 and P ≤ 0:01, respectively); levels of cox-2 decreased in normal and diabetic wounded groups at 0 h (P ≤ 0:001)
and increased in the diabetic and diabetic wounded groups at 48 h postirradiation (P ≤ 0:05 and P ≤ 0:01, respectively), while
levels of IL-6 decreased in the normal (P ≤ 0:01), diabetic (P ≤ 0:05), and diabetic wounded (P ≤ 0:001) groups at 24 h and in the
diabetic and diabetic wounded groups at 48 h (P ≤ 0:05) postirradiation. TNF-α was decreased in the normal wounded groups
(P ≤ 0:05) at 48 h. Through its effect on decreased IL-6 levels in diabetic cell models, PBM at 660 nm may be successful at
decreasing oxidative stress; however, the present study also found an increase in cox-2 levels at 48 h postirradiation.
1. Introduction
Photobiomodulation (PBM) uses light in the form of LASERs
(light amplification by stimulated emission of radiation) and
LEDs (light-emitting diodes) to stimulate and affect physio-
logical processes in organisms at the molecular and cellular
level. PBM has been shown to affect numerous pathways
and molecules important to the wound healing process, and
recently, our lab has shown that PBM controls the transcrip-
tion of genes and stimulates cellular signaling in diabetic
wounds [1, 2]. Wound healing comprises overlapping pro-
cesses that occur in a certain sequence to ensure efficient tis-
sue repair. The inflammatory response occurs during the
early stages of wound healing (typically between days 1 and
3) and is initiated by molecular signals released by damaged
tissue. The result is the initiation of biochemical signaling
pathways ultimately aiming to heal the injured tissue [3, 4].
Injured cells release chemokines stimulating the chemo-
taxis of leukocytes into the area by binding to selective recep-
tors. Cytokines released by the activated leukocytes cause
inflammation [5]. Vascular responses in the inflammatory
phase result in redness, edema, and warmth, while nerve
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stimulation leads to pain. This phase is important in keeping
infectious agents at bay while promoting healing [6]. Leuko-
cyte activity within the area eliminates microorganism threat
and clears the area of debris [3, 7]. The macrophages that
filtrate into the wounded area release a variety of cytokines
including interleukin- (IL-) 1 beta, IL-6, IL-8, and tumour
necrosis factor α (TNF-α) [4]. This in turn leads to cycloox-
ygenase (cox) 2 expression [8]. Cyclooxygenase, or prosta-
glandin synthase, consists of the enzymes cox-1 and cox-2
that are responsible for metabolizing or catalysing arachi-
donic acid to prostaglandins, prostacyclins, and thrombox-
anes [9]. These enzymes are regarded as proinflammatory
and play a role in homeostatic and pathological systems.
While prostacyclin and thromboxane A2 cause vasoconstric-
tion necessary for hemostasis, prostaglandins (E and I series)
contribute to inflammation by increasing vascular perme-
ability and stimulating inflammatory cells [10, 11]. The
overexpression of cox-2 stimulates the activation of metallo-
proteinases resulting in direct destruction of the extracellular
matrix [12], and its overexpression thus contributes to
wounds that do not heal timeously.
Inflammatory cytokines released by macrophages and
neutrophils such as IL-6 and TNF-α stimulate inflammation
by interacting with their respective receptors. Once bound to
the receptor, intracellular signaling pathways are stimulated
resulting in inflammation [4, 5]. In normal wound healing,
apoptosis of cells involved in inflammation occurs. In order
for wound healing to proceed optimally and efficiently, the
inflammatory phase needs to conclude so that the other
phases of wound healing may continue. In diabetes mellitus,
the inflammatory phase continues indefinitely, and this,
combined with various other factors, accounts for impaired
wound healing [13]. The release of IL-6 and TNF-α is ele-
vated in hyperglycemic states contributing to the sustained
inflammatory response linked to delayed wound healing
[14, 15]. Connective tissue of the dermis consists primarily
of fibroblasts, and in tissue repair, their role in maintaining
the structural integrity of the dermis is indispensable.
Fibroblasts also release growth factors required for tissue
regeneration, and in diabetic woundsdecreased fibroblast
proliferation leads to wounds that do not heal well. In addi-
tion, when fibroblasts are stimulated, cytokines, chemokines,
and prostanoids are produced [16].
Additionally, in diabetes, the interplay between inflam-
mation and oxidative stress contributes to many of the prob-
lems associated with diabetes including foot ulcers that do
not heal [17, 18]. Oxidative stress occurs due to the accumu-
lation of oxygen-free radicals, and in diabetes, enhanced
glucose metabolism accounts for the rise in oxidative stress.
Free radicals are produced mainly by the mitochondria as
metabolites or through the NADPH oxidases in cells and
are required for normal physiological processes such as cell
growth, differentiation, apoptosis, and activation of certain
transcription factors [19]. The antioxidant system is neces-
sary in eliminating excess free radicals. If the balance between
the two is impaired in favour of the free radicals, pathological
states arise [18, 20]. Increased levels of reactive oxygen spe-
cies (ROS) contribute to increased levels of inflammatory
cytokines, and enhanced inflammation can further the pro-
duction of oxidative stress, thus, having an unfavourable
effect on cells and tissues [21]. Esposito and colleagues
suggest that in hyperglycaemia, an oxidative mechanism is
a likely source for the production of IL-6 and TNF-α [22].
The authors found that the antioxidant glutathione impeded
any further increase in IL-6 and TNF-α, thus, indicating that
the levels of these cytokines increase with oxidative stress
[22]. Activated cox-2 also leads to the production of ROS in
mechanically wounded keratinocytes through the ROS-cox-
2/PGE2 pathway [23].
PBM therapy and PBM has been shown to affect inflam-
mation, inflammatory markers and cytokine production, and
oxidative stress [24–27]. In the present study, we investigated
the levels of cox-2, IL-6, and TNF-α postirradiation at
660 nm in diabetic wounded fibroblast cell culture models.
2. Materials and Methods
2.1. Cell Culture Models. Ethical clearance was obtained from
the University of Johannesburg’s Faculty of Health Sciences
Research Ethics Committee (REC-01-98-2017). Four models
of WS1 human skin fibroblast cells (ATCC®, CRL-1502™)
were used in the study: normal (N), normal wounded
(NW), diabetic (D), and diabetic wounded (DW). Cells were
grown in Eagles Minimum Essential (MEM) medium con-
taining 1.5 g/L sodium bicarbonate and Earls balanced salts.
As previously described, D-glucose (17mM/L) was added
to MEM to achieve the diabetic models [28]. The media
was changed twice weekly, and once cells reached a conflu-
ence of 80-90%, they were seeded in 3.4 cm diameter tissue
culture plates at a density of 6 × 105 cells per plate. Cell
attachment to the tissue culture plates occurred when incu-
bated at 37°C in 5% CO2. Prior to irradiation, culture media
was discarded, and cells were rinsed with prewarmed Hanks
Balanced Salt Solution and then replaced with 1mL fresh
media. To achieve the wounded model, a central scratch was
made in the confluent cellular monolayer using a sterile
1mL pipette [28]. Before the cells were irradiated, the tissue
culture plates were incubated for 30min and cell culture media
collected at 0, 24, and 48h postirradiation. Cell culture media
was stored at -80°C and used within 6 weeks of collection.
2.2. Laser Irradiation. All lasers were supplied and set up by
the National Laser Centre (NLC), Council for Scientific and
Industrial Research (CSIR). Laser parameters are provided
in Table 1. Previous studies in the same cell models have
shown that a wavelength of 660nm and a fluence of 5 J/cm2
have stimulated diabetic wounded cells [29–31]. Thus, in this
study, a diode laser emitting at a wavelength of 660 nm and a
fluence of 5 J/cm2 was used. Nonirradiated cells (0 J/cm2)
served as controls. To prevent nuisance variables suggestive
of polychromatic light that would normally interfere with
the laser effect, laser irradiation took place in the dark and
from above with the absence of the tissue culture dish lid.
2.3. Cell Morphology and Viability.Morphological changes in
the cells were determined using light microscopy (Olympus
CKX41). The Trypan Blue exclusion assay was used to deter-
mine cell viability. Equal volumes of Trypan Blue dye (0.4%;
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Sigma-Aldrich T8154) and cell suspension (10μl) were
pipetted together and allowed to briefly stain. The mixture
was loaded onto a Countess™ Cell Counting Chamber Slide
and counted on the Invitrogen Countess™ II FL Automated
Cell Counter immediately. Nonviable cells have compro-
mised cell membranes and therefore stain blue as the dye
enters the cells. Viable cells with undamaged cell membranes
remain clear.
2.4. Enzyme-Linked Immunosorbent Assay (ELISA).We used
ELISA kits to determine levels of cox-2 (Sigma-Aldrich™
RAB1034), IL-6 (Sigma-Aldrich™; RAB0306), and TNF-α
(Sigma-Aldrich™; RAB0476) according to the manufac-
turer’s instructions. Briefly, 100μL of each standard and
100μL of sample (thawed culture media) were added into
the wells of a 96-well plate. The plate was covered and left
overnight at 4°C. The standard and samples were discarded
and the plate washed four times with wash solution. The
detection antibody (100μL) was then added to each well,
and the plate was incubated for 1 h at room temperature with
gentle shaking. Once the plate was washed four times with
wash solution, 100μL of HRP-streptavidin was added to each
well. The plate was incubated for 45min at room tempera-
ture. The plate was again washed four times with the wash
solution, and 100μL of the ELISA colorimetric TMB reagent
was added to each well. The plate was incubated for 30min at
room temperature in the dark. Stop solution was added, and
the plate was read at 450nm immediately on the Victor3
multiplate reader (Perkin-Elmir).
2.5. Statistical Analysis. The experiments were performed
three times (n = 3), and all assays were prepared in duplicate.
The paired t-test was used to determine if any statistical
differences existed between the nonirradiated (0 J/cm2) and
the irradiated (5 J/cm2) groups within each model (normal,
normal wounded, diabetic, and diabetic wounded) at the
different time intervals. To determine if PBM at 660nm
had an effect on the overall levels of cox-2, IL-6, and TNF-α
at 0, 24, and 48 h postirradiation, irrespective of model, a
two-way ANOVA with a Tukey’s post hoc test was used.
Results are demonstrated as mean ± SD, and P ≤ 0:05 was
considered significant. Statistics were performed using
IBM® SPSS® Statistics for Windows Version 26 (IBM Corp.,
Armonk, NY, USA).
3. Results
3.1. Cell Morphology. Morphological changes in WS1 cells
and the wound gap width, created by the central scratch,
are demonstrated in Figures 1 and 2. There were no notice-
able morphological changes in the nonirradiated and irradi-
ated cells over the 48h period in both normal (Figure 1)
and diabetic (Figure 2) groups. Fibroblast proliferation
increased in cells exposed to irradiation (5 J/cm2). In the
wounded groups, wound closure occurred faster in the irradi-
ated groups (Figures 1 and 2(g)–2(l)). All cells grew as a
monolayer and displayed strong adhesion properties.
3.2. Cell Viability. The Trypan Blue exclusion assay is used to
determine the approximate percentage of viable (or live) and
nonviable (or dead) cells in a sample. Table 2 represents the
percentage viability of cells. Cell viability significantly
increased in the diabetic wounded irradiated group at 0 and
24 h when compared to the nonirradiated groups.
3.3. ELISA. Enzyme-linked immunosorbent assays were per-
formed to measure the levels of cox-2, IL-6, and TNF-α in the
nonirradiated and irradiated groups, and results are shown in
Figures 3–8. Cox-2 levels initially decreased (at 0 h) between
nonirradiated and irradiated cells in the normal (P = 0:007)
and diabetic wounded (P = 0:009) groups; however, levels
of cox-2 increased in both diabetic (P = 0:016) and diabetic
wounded (P = 0:005) groups at 48 h postirradiation
(Figure 3). Statistics for the two-way ANOVA showed that
PBM significantly decreased cox-2 levels at 0 h (P ≤ 0:001);
however, there was an increase in cox-2 levels at 48 h postir-
radiation (P = 0:013) (Figure 4).
IL-6 levels decreased in the diabetic group after irradia-
tion (5 J/cm2; 660nm) at 0 h, although the change was not
significant. The most noticeable differences in IL-6 levels
occurred 24h postirradiation where a statistically significant
decrease in IL-6 levels was measured in the normal
(P = 0:006), diabetic (P = 0:016), and diabetic wounded
(P = 0:001) groups (Figure 5). Furthermore, IL-6 levels
decreased substantially in the diabetic group (P = 0:02) and
in the diabetic wounded group (P = 0:05) 48 h postirradia-
tion. At 0, 24, and 48h, the levels of IL-6 were significantly
higher in both the diabetic and diabetic wounded groups as
compared to the normal and normal wounded groups,
respectively (P ≤ 0:001), and this is indicative of an increased
oxidative stress in the models receiving 17mmol/L D-
glucose. Statistics for the two-way ANOVA showed that
PBM was successful at significantly decreasing the levels of
IL-6 at 0 h (P = 0:041), 24 h (P ≤ 0:001), and 48 h (P ≤ 0:001)
postirradiation (Figure 6).
The only significant decrease in TNF-α levels occurred in
the irradiated normal wounded group at 48h (P = 0:034).
TNF-α also decreased in the experimental diabetic and dia-
betic wounded groups at 48 h postirradiation, although no
statistical significance was reached (Figure 7). Statistics for
the two-way ANOVA showed that PBM decreased the levels
of TNF-α at 0 h (P ≤ 0:001); however, the decrease was not
significant at 24 and 48 h postirradiation (Figure 8).





Power output (mW) 101:25 ± 5:91
Power density (mW/cm2) 11:15 ± 0:65
Fluency (J/cm2) 5
Energy (J) 45:53 ± 0:15
Spot size (cm2) 9.1
Irradiation time (± min, s) 7min and 29 s ± 24:56 s
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Figure 1: Morphology of normal (N) and normal wounded (NW) fibroblasts irradiated at 660 nm with 5 J/cm2 and measured over various
time intervals. Nonirradiated cells (0 J/cm2) served as controls.





Figure 2: Morphology of diabetic (D) and diabetic wounded (DW) fibroblasts irradiated at 660 nm with 5 J/cm2 and measured over various
time intervals. Nonirradiated cells (0 J/cm2) served as controls.
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4. Discussion
In normal wounds, tissue repair follows a chronological
sequence of events beginning with hemostasis and inflamma-
tion. The inflammatory phase serves as a protective essential
step in order for tissue repair to successfully proceed. In
wounds that display ineffective healing, such as those wounds
in diabetics, the inflammatory stage of tissue repair becomes
persistent and ineffective at protecting the wound from pos-
sible infections, and impaired wound healing in diabetes
often leads to diabetic foot ulcers [13]. High glucose levels,
through the intake of glucose, prompts oxidative stress
through ROS and inflammation due to the expression of
TNF-α in mononuclear cells, and it is suggested that these
factors contribute to the proinflammatory state in diabetic
wounds [13, 32–34]. In addition, high glucose stimulates
the expression of IL-6 in mice [33]. In diabetic wounds, the
increase in the cox-2/PGE2 pathway in macrophages leads
to inflammation and decreased phagocytosis [35]. Addition-
ally, an increase in ROS and elevated oxidative stress has also
been associated with diabetes [36]. As prolonged inflamma-
tion and oxidative stress are linked to unsuccessful wound
healing in patients with diabetes, we investigated the effects
of PBM on the proinflammatory cytokines IL-6 and TNF-α,
as well as the proinflammatory mediator cox-2 in diabetic
wounded fibroblast cell culture models. Our results show that
PBM at 660nm and 5 J/cm2 decreased cox-2 levels immedi-
ately after irradiation in the normal and diabetic wounded
groups; however, levels of cox-2 seemed to increase in dia-
betic and diabetic wounded groups 48h postirradiation
(Figures 3 and 4). The present results also show that PBM
at 660 nm and 5 J/cm2 can significantly decrease the levels
of IL-6 in diabetic and diabetic wounded models at 24 and
48 h postirradiation and decrease TNF-α levels in the diabetic
and diabetic wounded models at 48 h postirradiation;
however, this decrease was not statistically significant
(Figures 5–8). The wound gap that was created by a central
scratch also improved in the normal wounded and diabetic
wounded groups postirradiation across a 48 h period
(Figures 1 and 2).
In response to injurious stimuli, histamines, leukotrienes,
and prostaglandins (PGs) are released due to mast cell activa-
tion and degranulation. Furthermore, when tissue injury
occurs, leukotrienes and PGs are produced by the breakdown
of membrane lipids by activated phospholipase A2 releasing
arachidonic acid, the precursor for these eicosanoids [37].
Arachidonic acid is metabolized by two important enzymes:
lipoxygenases producing the leukotrienes and cyclooxy-
genases- (cox-) 1 and -2 producing prostanoids (PGs, prosta-
cyclins, and thromboxanes) [38]. PGs include prostaglandin
E2, prostacyclin, prostaglandin D2, and prostaglandin F2α
[39]. While cox-1 is important for normal physiological pro-
cesses, both isoforms of cox lead to prostanoid production
during inflammation; however, cox-2 is the more significant
enzyme leading to prostanoid production in inflammation
[39]. Activated cox-2 leads to vascular changes and leukocyte
infiltration due to the effects of PGE2 in wound healing.
Vasodilation and increased capillary permeability occur due
to the action of PGE2 leading to the typical signs of inflam-
mation: redness and swelling, while the effect of PGE2 on
sensory neurons leads to the sensation of pain [39, 40].
In the current study, a decrease in human cox-2 levels in
normal and diabetic wounded cells occurred at 0 h postirra-
diation. Interestingly, an increase in cox-2 was noted in the
diabetic and diabetic wounded group at 48 h postirradiation.
Petrellis and colleagues found that the gene expression of
cox-2 increased with a 1 J energy dose among the various
treatment and control groups in Walker tumour-induced
Wistar rats [41]. The increase in cox-2 levels postirradiation
is not easy to explain currently as the literature states that
cox-2 is implicated in the inflammatory response; however,
it is possible that cox-2 may be involved in decreasing inflam-
mation through the production of anti-inflammatory prosta-
glandins but literature on this is scarce.
In response to injury, M1 phenotypemacrophages release
IL-6 and TNF-α, and in Type 2 diabetes mellitus, levels of
these cytokines are elevated [3, 15]. TNF-α in particular plays
a vital role in insulin resistance and tissue inflammation [42,
43]. Both forms of TNF-α, the soluble form and its precursor
transmembrane form, play a pivotal role in inflammation
once bound to TNF-α receptors [44]. IL-6 is released by a
variety of cells including fibroblasts, and it has many func-
tions in addition to promoting inflammation [45].
In the present study, TNF-α levels decreased in the irra-
diated (experimental) diabetic models at 24 and 48 h, and
in the irradiated (experimental) diabetic wounded models
at 0 and 48 h, however, the differences did not reach statisti-
cal significance. Our study also found that levels of the IL-6
Table 2: The Trypan Blue exclusion assay was performed to assess
cellular viability (%) of nonirradiated (0 J/cm2) and irradiated cells
(5 J/cm2) at 0, 24, and 48 h postirradiation. An increase in cell
viability was noted in the diabetic wounded group at 0 and 24 h
postirradiation.
Nonirradiated cells
(0 J/cm2) % viability (± SD)
Irradiated cells (5 J/cm2)
% viability (± SD)
Normal
0 h 89 (±3) 89.67 (±5.5)
24 h 66 (±7) 77.33 (±6.506)
48 h 91 (±2.646) 86.33 (±1.528)
Normal
wounded
0 h 92 (±6.08) 92.67 (±2.08)
24 h 71.67(±10.066) 76 (±4.359)
48 h 74.67 (±7.234) 86 (±2)
Diabetic
0 h 55.33 (±4.041) 59 (±3.464)
24 h 70 (±6) 78.33 (±4.619)
48 h 82 (±6.254) 89.67 (±2.517)
Diabetic
wounded
0 h 57 (±3.464) 73 (±8.718)∗
24 h 58.33 (±3.055) 83 (±5.292)∗∗
48 h 90.33 (±2.309) 90.33 (±3.215)
∗P ≤ 0:05; ∗∗P ≤ 0:01.
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cytokine decreased significantly in irradiated diabetic and
diabetic wounded groups at both 24 h and 48 h. This finding
is similar to Petrellis et al. who reported that at the same
wavelength of 660nm, IL-6 and TNF-α levels were signifi-
cantly reduced in their tumour experimental groups, whereas





































Figure 4: Human cox-2 levels in WS1 fibroblasts receiving no irradiation (0 J/cm2) or irradiation (5 J/cm2) at 660 nm at (a) 0 h, (b) 24 h, and

















Figure 3: Human cox-2 levels in WS1 fibroblasts in normal, normal wounded, diabetic, and diabetic wounded cells irradiated at 660 nm with
5 J/cm2 and measured at (a) 0 h, (b) 24 h, and (c) 48 h postirradiation. Nonirradiated cells (0 J/cm2) served as controls. Results represent the
mean of three repeats ðn = 3Þ ± standard deviation. The paired t-test was used to determine differences in each model between the irradiated
cells and the control. ∗P ≤ 0:05; ∗∗P ≤ 0:01; ∗∗∗P ≤ 0:001.








































































Figure 6: Human IL-6 levels inWS1 fibroblasts receiving no irradiation (0 J/cm2) or irradiation (5 J/cm2) at 660 nm at (a) 0 h, (b) 24 h, and (c)













Figure 5: Human IL-6 levels in WS1 fibroblasts in normal, normal wounded, diabetic, and diabetic wounded cells irradiated at 660 nm with
5 J/cm2 and measured at (a) 0 h, (b) 24 h, and (c) 48 h postirradiation. Nonirradiated cells (0 J/cm2) served as controls. Results represent the
mean of three repeats ðn = 3Þ ± standard deviation. The paired t-test was used to determine differences in each model between the irradiated
cells and the control. ∗P ≤ 0:05; ∗∗P ≤ 0:01; ∗∗∗P ≤ 0:001.
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the groups receiving an energy dose of 3 J and 6 J [41]. Sale-
hpour et al. found a reduction in serum IL-6 and TNF-α
levels in the neural tissues of mice after receiving 5 days of
PBM at 810nm and 33.3 J/cm2. These differences were noted
in the groups that received PBM only, coenzyme Q10 only,
and when a combination of both was used [26]. Our results
are contradictory to Fernandes et al. who found an increase

















Figure 7: Human TNF-α levels in WS1 fibroblasts in normal, normal wounded, diabetic, and diabetic wounded cells irradiated at 660 nm
with 5 J/cm2 and measured at (a) 0 h, (b) 24 h, and (c) 48 h postirradiation. Nonirradiated cells (0 J/cm2) served as controls. Results
represent the mean of three repeats ðn = 3Þ ± standard deviation. The paired t-test was used to determine differences in each model





































Figure 8: Human TNF-α levels inWS1 fibroblasts receiving no irradiation (0 J/cm2) or irradiation (5 J/cm2) at 660 nm at (a) 0 h, (b) 24 h, and
(c) 48 h postirradiation. Results are represented as the mean ± standard deviation. ∗P ≤ 0:05; ∗∗P ≤ 0:01; ∗∗∗P ≤ 0:001.
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macrophage-like cells irradiated with a 660nm laser. The
increase in IL-6 levels could not easily be explained by the
researchers; however, the study found a decrease in TNF-α
expression, and a downregulation of TNF- α and cox-2 pro-
tein production in the J774 cells irradiated at 660 nm
(7.5 J/cm2) and 780 nm (2.6 J/cm2), with the latter wavelength
causing more of a decrease [25].
An elevation in ROS generation after PBM at 660 nm
in vitro and in vivo was noted by Rupel and colleagues,
whereas ROS generation decreased when other wavelengths
of light were used in their study [46]. Our lab recently
showed that in diabetic fibroblast models, PBM at 660 nm
and 5 J/cm2 is effective in decreasing oxidative stress through
the inhibition of the FOXO1 signaling pathway [31]. The
current study provides a possible alternative mechanism
through which PBM may be effective at decreasing oxidative
stress by lowering the levels of IL-6 in diabetic models; how-
ever, a study evaluating the effect of PBM at 660nm on both
IL-6 and oxidative stress is required to confirm this.
5. Conclusions
In conclusion, the present study shows that PBM at 660 nm
and 5 J/cm2 decreases the levels of the proinflammatory cyto-
kine IL-6 in diabetic wounded WS1 fibroblasts, and this
decrease is most apparent at 48 h postirradiation. The data
is consistent with most of the studies on the effects of PBM
using various wavelengths on IL-6. Interestingly, our study
found an initial decrease in cox-2 levels, which then increased
at 48h postirradiation, but more studies are needed to deter-
mine if and why this increase may occur. In the present
study, levels of TNF-α decreased at 48 h in the diabetic and
diabetic wounded groups; however, the differences did not
reach statistical significance.
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